These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 14742188

  • 1. Oral treatment of cowpox and vaccinia virus infections in mice with ether lipid esters of cidofovir.
    Quenelle DC, Collins DJ, Wan WB, Beadle JR, Hostetler KY, Kern ER.
    Antimicrob Agents Chemother; 2004 Feb; 48(2):404-12. PubMed ID: 14742188
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of multiple- or single-dose cidofovir against vaccinia and cowpox virus infections in mice.
    Quenelle DC, Collins DJ, Kern ER.
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3275-80. PubMed ID: 14506041
    [Abstract] [Full Text] [Related]

  • 3. Oral treatment of murine cytomegalovirus infections with ether lipid esters of cidofovir.
    Kern ER, Collins DJ, Wan WB, Beadle JR, Hostetler KY, Quenelle DC.
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3516-22. PubMed ID: 15328119
    [Abstract] [Full Text] [Related]

  • 4. Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir.
    Quenelle DC, Collins DJ, Kern ER.
    Antiviral Res; 2004 Jul; 63(1):33-40. PubMed ID: 15196818
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of oral treatment with hexadecyloxypropyl-[(S)-9-(3-hydroxy-2- phosphonylmethoxypropyl)adenine] [(S)-HPMPA] or octadecyloxyethyl-(S)-HPMPA on cowpox or vaccinia virus infections in mice.
    Quenelle DC, Collins DJ, Herrod BP, Keith KA, Trahan J, Beadle JR, Hostetler KY, Kern ER.
    Antimicrob Agents Chemother; 2007 Nov; 51(11):3940-7. PubMed ID: 17846137
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir.
    Smee DF, Bailey KW, Wong M, Sidwell RW.
    Antiviral Res; 2000 Sep; 47(3):171-7. PubMed ID: 10974369
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis and antiviral evaluation of alkoxyalkyl-phosphate conjugates of cidofovir and adefovir.
    Ruiz JC, Beadle JR, Aldern KA, Keith KA, Hartline CB, Kern ER, Hostetler KY.
    Antiviral Res; 2007 Jul; 75(1):87-90. PubMed ID: 17367874
    [Abstract] [Full Text] [Related]

  • 12. Treatment of lethal cowpox virus respiratory infections in mice with 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine and its orally active diacetate ester prodrug.
    Smee DF, Bailey KW, Sidwell RW.
    Antiviral Res; 2002 May; 54(2):113-20. PubMed ID: 12062396
    [Abstract] [Full Text] [Related]

  • 13. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses.
    Smee DF, Sidwell RW, Kefauver D, Bray M, Huggins JW.
    Antimicrob Agents Chemother; 2002 May; 46(5):1329-35. PubMed ID: 11959564
    [Abstract] [Full Text] [Related]

  • 14. Oral activity of ether lipid ester prodrugs of cidofovir against experimental human cytomegalovirus infection.
    Bidanset DJ, Beadle JR, Wan WB, Hostetler KY, Kern ER.
    J Infect Dis; 2004 Aug 01; 190(3):499-503. PubMed ID: 15243923
    [Abstract] [Full Text] [Related]

  • 15. Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir.
    Smee DF, Bailey KW, Sidwell RW.
    Antivir Chem Chemother; 2001 Jan 01; 12(1):71-6. PubMed ID: 11437324
    [Abstract] [Full Text] [Related]

  • 16. Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice.
    Smee DF, Bailey KW, Sidwell RW.
    Chemotherapy; 2003 Jun 01; 49(3):126-31. PubMed ID: 12815205
    [Abstract] [Full Text] [Related]

  • 17. Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice.
    Smee DF, Bailey KW, Wong MH, Sidwell RW.
    Antiviral Res; 2001 Oct 01; 52(1):55-62. PubMed ID: 11530188
    [Abstract] [Full Text] [Related]

  • 18. Increased antiviral activity of 1-O-hexadecyloxypropyl-[2-(14)C]cidofovir in MRC-5 human lung fibroblasts is explained by unique cellular uptake and metabolism.
    Aldern KA, Ciesla SL, Winegarden KL, Hostetler KY.
    Mol Pharmacol; 2003 Mar 01; 63(3):678-81. PubMed ID: 12606777
    [Abstract] [Full Text] [Related]

  • 19. Effects of four antiviral substances on lethal vaccinia virus (IHD strain) respiratory infections in mice.
    Smee DF, Wong MH, Bailey KW, Beadle JR, Hostetler KY, Sidwell RW.
    Int J Antimicrob Agents; 2004 May 01; 23(5):430-7. PubMed ID: 15120719
    [Abstract] [Full Text] [Related]

  • 20. Esterification of cidofovir with alkoxyalkanols increases oral bioavailability and diminishes drug accumulation in kidney.
    Ciesla SL, Trahan J, Wan WB, Beadle JR, Aldern KA, Painter GR, Hostetler KY.
    Antiviral Res; 2003 Aug 01; 59(3):163-71. PubMed ID: 12927306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.